Journal of Chinese Integrative Medicine ›› 2005, Vol. 3 ›› Issue (2): 99-102.doi: 10.3736/jcim20050205
• Original Clinical Research • Previous Articles Next Articles
Ying-lu Feng,Chang-quan Ling,De-zeng Zhu,Chao-qin Yu,Zhe Chen,Bai Li
CLC Number:
[1] |
Attele AS, Wu JA, Yuan CS . Ginseng pharmacology: multiple constituents and multiple actions[J]. Biochem Pharmacol, 1999,58(11):1685-1693
doi: 10.1016/S0006-2952(99)00212-9 |
[2] |
Kong X, Hu Y, Rui R , et al. Effects of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody titer after vaccination in chicken[J]. Int Immunopharmacol, 2004,4(7):975-982
doi: 10.1016/j.intimp.2004.03.008 |
[3] | 中国抗癌协会肝癌专业委员会. 原发性肝癌的临床诊断与分期标准[J]. 中华肝脏病杂志, 2001,9(6):324 |
[4] |
王建华, 周康荣 . 肝癌综合性介入治疗规范化方案(草案)[J]. 临床放射学杂志, 2002,21(7):497-500
doi: 10.3969/j.issn.1001-9324.2002.07.004 |
[5] | 周际昌 . 实用肿瘤内科学(第1版)[M]. 北京: 人民卫生出版社, 2003,( 第1版):424 |
[6] | 权启镇 . 新肝脏病学(第1版)[M]. 济南: 山东科学技术出版社, 2003,( 第1版):111 |
[7] | 吴一萍, 张毅 . 糖皮质激素在肿瘤并发症中的应用[J]. 临床肿瘤学杂志, 2001,6(4):387-388 |
[8] | 陈颖, 陈燕茹 . 防治肝癌介入术后迟发性恶心呕吐的观察[J]. 护士进修杂志, 2003,18(4):374-375 |
[9] | Yun TK .Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds[J].Mutat Res, 2003, 523-524: 63-74 |
[10] |
Lee EJ, Ko E, Lee J , et al. Ginsenoside Rg1 enhances CD4+ T-cell activities and modulates Th1/Th2 differentiation[J]. Int Immunopharmacol, 2004,4(2):235-244
doi: 10.1016/j.intimp.2003.12.007 pmid: 14996415 |
[11] | 窦德强, 靳玲, 陈英杰 . 人参的化学成分及药理活性的研究进展与展望[J]. 沈阳药科大学学报, 1999,16(2):151-155 |
[1] | Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525. |
[2] | Hao Gou, Ruo-chen Huang, Yong-hua Su, Wei Li. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer. Journal of Integrative Medicine, 2021, 19(5): 408-417. |
[3] | Liang Ding, Xin-you Zhang, Di-yao Wu, Meng-ling Liu. Application of an extreme learning machine network with particle swarm optimization in syndrome classification of primary liver cancer. Journal of Integrative Medicine, 2021, 19(5): 395-407. |
[4] | Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248. |
[5] | Lin Jia, Wan-yin Wang, Li-mei Zhou, Feng-feng Mo, Min Li. Antimotion sickness effects of ginsenosides combined with dexamethasone in rats. Journal of Chinese Integrative Medicine, 2010, 8(4): 358-362. |
[6] | Huo-jun Zhang, Ji-jin Yang, Wei-xing Wang, Xu Jiang, Yan-jun Mao, Chao-ai Yang, Ji-xiang Guo. Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy. Journal of Chinese Integrative Medicine, 2008, 6(9): 907-910. |
[7] | Zhi-qiang Pan, Zhao-qin Fang, Wen-li Lu, Chao Liang, Zhong-hua Wu, Xiao-mei Liu, Li Hou, Hui Zhang, Shao-yuan Zhuo, Ming-juan Liao, Bi-feng Gao. Differentially expressed genes in adrenal gland of H22 liver cancer mice with different syndromes and in different stages. Journal of Chinese Integrative Medicine, 2008, 6(8): 843-851. |
[8] | Zhi-jun Dai, Xi-jing Wang, Qian Xue, Zong-zheng Ji, Xiao-xu Liu, Hua-feng Kang, Hai-tao Guan, Xiao-bin Ma, Hong-tao Ren. Effects of Scutellaria Barbata drug-containing serum on apoptosis and mitochondrial transmembrane potential of hepatoma H22 cells. Journal of Chinese Integrative Medicine, 2008, 6(8): 821-826. |
[9] | Zhi-jun Dai, Xi-jing Wang, Zong-zheng Ji, Zong-fang Li, Wei Tang, Hua-feng Kang, Xiao-bin Ma, Lei Liu. Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(7): 720-724. |
[10] | Hong-yun Chen, Zhe Chen. Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review. Journal of Chinese Integrative Medicine, 2008, 6(4): 422-426. |
[11] | Yu Hao, Ping Wang, Jun Wu, Quan-ying Qiu. Effects of ginsenoside and berberine on secretion of immunosuppressive cytokines in lung carcinoma cell line PG. Journal of Chinese Integrative Medicine, 2008, 6(3): 278-282. |
[12] | Hai-bo Yu, Cheng-en Pan, Wu-jun Wu, Si-hai Zhao, Hui-feng Zhang. Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells. Journal of Chinese Integrative Medicine, 2008, 6(3): 270-273. |
[13] | Zhen Sun, Yong-hua Su, Xiao-qiang Yue. Professor Ling Changquan's experience in treating primary liver cancer: an analysis of herbal medication. Journal of Chinese Integrative Medicine, 2008, 6(12): 1221-1225. |
[14] | A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82. |
[15] | Chen Zhang, Bai Li, Shu-qin Lu, Yong Li, Yong-hua Su, Chang-quan Ling. Effects of melittin on expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and Fas Ligand in hepatocarcinoma cells. Journal of Chinese Integrative Medicine, 2007, 5(5): 559-563. |